Professor of Medicine & Chief, Division of Gastrointestinal and Liver Diseases Keck School of Medicine, University of Southern California Los Angeles, CA
Discuss diagnosis of patients at risk for reactivation of hepatitis B, immunosuppression drug classes requiring hepatitis B therapy, monitoring strategies, and treatment cessation timelines.